Azure Health Technology Limited (NSX:VTL) Initiation Report
Azure Health Technology Limited (NSX:VTL) trading as VGI Health Technology is pleased to announce that Pitt Street Research has issued an Initiation Report.
Companies in the News
Drugs & OTC
Azure Health Technology Limited (NSX:VTL) Appointment of cGMP Manufacturer
Azure Health Technology Limited trading as VGI Health Technology (NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US.
Anatara Lifesciences Ltd (ASX:ANR) Progressing Towards First Human Clinical Studies
Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities.
Anatara Lifesciences Ltd (ASX:ANR) Q3 FY21 Activities Report
Anatara Lifesciences (ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company's Appendix 4C cash flow report.
Anatara Lifesciences Ltd (ASX:ANR) Ethics Approve Adult Psychological Functioning Trial start
Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial on the effects of 3FDC dietary supplementation on psychological functioning in an adult population.
Anatara Lifesciences Ltd (ASX:ANR) Announces Australian Patent Grant for Detach
Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce the grant of patent number AU2019204496 entitled "Anti-diarrhea formulation which avoids antimicrobial resistance".
Anatara Lifesciences Ltd (ASX:ANR) Market Update
Anatara is pleased that activities for the March quarter progressed favourably and near to anticipated timelines. There appears to be a wider appreciation of Anatara's human health initiatives with a focus on using the restoration and/or maintenance of gastrointestinal tract harmony to improve overall wellbeing.
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
- Deep Yellow Limited (ASX:DYL) Tumas Project Update
- Central Petroleum Limited (ASX:CTP) LOI Signed for New Drilling and Long-Term Gas Supply
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
Social Media
